C=C1CCC[C@]2(C)C[C@H]3OC(=O)C(CN4CCOCC4)[C@H]3C[C@@H]12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?